PAC120 xenograft is a new model of hormone-dependent prostate cancer, opening the opportunity to study the hormone dependence escape mechanism and to evaluate the efficacity of new therapeutics

Legrier, M. E., de Pinieux, G., Poirson-Bichat, F., Apiou, F., Dutrillaux, A. M., Boye, K., Sihassen, A., Lidereau, R., Bara, J., Arvelo, F., Poupon, M.F.

Pathol Biol (Paris) (2003) 51, 1-4.